Browse Category

Stock Market News News 15 December 2025

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group Incorporated (NYSE: UNH) is back in the spotlight as 2025 winds down—caught between “defensive” sector rotation, fresh legal headlines, and a fast-approaching earnings and guidance reset that could shape sentiment for 2026. As of 15:27 UTC on Monday,
BitMine Immersion Technologies (BMNR) Stock News Today: ETH Treasury Update, Share Vote Risks, Analyst Targets, and Technical Outlook (Dec. 15, 2025)

BitMine Immersion Technologies (BMNR) Stock News Today: ETH Treasury Update, Share Vote Risks, Analyst Targets, and Technical Outlook (Dec. 15, 2025)

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is back in the spotlight on December 15, 2025—not because it suddenly became a conventional operating company, but because it has increasingly traded like a publicly listed Ethereum (“ETH”) proxy with corporate actions
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

December 15, 2025 — WORK Medical Technology Group LTD stock (Nasdaq: WOK) is back on traders’ radar as a hyper-volatile micro-cap with a story that reads like a corporate-actions speedrun: Nasdaq bid-price warnings, a 1-for-100 reverse stock split, rapid swings
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as
1 25 26 27 28 29 46
Go toTop